NASDAQ:ATRA

Atara Biotherapeutics, Inc Earning Date

USA |NASDAQ |USD

ATRA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.94 $-0.91 $-0.92
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $4.48M $3.87M $0.00

Atara Biotherapeutics, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

ATRA Earnings Date & History Chart

ATRA Earnings & Revenue Forecast

ATRA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.81 $-1.14 $-0.48
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-3.52 $-3.88 $-3.13
Dec 2022 9 $-3.37 $-3.98 $-2.91

ATRA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-0.98 $-0.93 $-0.93
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-3.70 $-3.59 $-3.59
Dec 2022 4 / 0 $-3.55 $-3.41 $-3.41

ATRA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $18.77M $4.00M $50.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $29.87M $15.00M $62.00M
Dec 2022 9 $49.33M $19.00M $77.00M

ATRA Earnings Date & Revenue History

ATRA Earnings History

|
Show More
Show More

ATRA Revenue History

|
Show More
Show More

Atara Biotherapeutics, Inc Next Earnings Date & Report

ATRA Next Earnings Date & Report Preview: Sep 2021 (FQ)

ATRA's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 9 analysts, the average EPS estimation for Atara Biotherapeutics, Inc's next quarterly earnings is $-0.94, with a low EPS estimation of $-1.00, and a high estimation of $-0.85.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.94, the last 2 month trend is $-0.91, and the 3 month trend is $-0.91.

Based on 9 analysts, the average revenue estimation is $4.48M, with a low revenue estimation of $0.00, and a high estimation of $8.87M.

Atara Biotherapeutics, Inc Previous Earnings Dates & Reports

ATRA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Atara Biotherapeutics, Inc's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

ATRA's earnings per share (EPS) was $-0.91, missing the consensus analysts forecast of $-0.87 by -4.26%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 5.81%, and higher than the same period a year before (Jun 2020) by -20.18%.

Revenues were $3.87M.

The company reported a net income of $-83.79M.

Free cash flow for the quarter was $-131.53M , compared to $-67.89M last quarter and $-58.71M a year before.

ATRA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Atara Biotherapeutics, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

ATRA's earnings per share (EPS) was $-4.21, missing the consensus analysts forecast of $-3.93 by 7.12% , and higher than the previous year's EPS (Dec 2019) by -26.27%.

Revenues were $0.00.

The company reported a net income of $-306.62M.

Atara Biotherapeutics, Inc reported a free cash flow of $-185.27M for its fiscal year, compared to $-241.36M a year ago.

The company ended the fiscal year with $15.03M in total debt, a decrease of -4.40% compared to the previous year.